Interventions for H1N1 Influenza: cost-effectiveness
Citation: Pasquini-Descomps H, Brender N, Maradan D. Value for Money in H1N1 Influenza: A Systematic Review of the Cost-Effectiveness of Pandemic Interventions. Value in Health 2017; 20: 819-27
What is this? The COVID-19 pandemic is placing a great strain on health systems and economies. Information on the cost-effectiveness of interventions used in other pandemics might help those making decisions about interventions for COVID-19.
In this systematic review, the authors searched for studies that presented cost-effectiveness or cost-benefit analyses for A/H1N1 pandemic interventions. They did their search in December 2014. They identified 18 studies that assessed the cost-effectiveness of 12 different strategies. All studies examined costs from a societal perspective.
What was found: Hospital quarantine, vaccination and use of an antiviral stockpile were highly cost-effective for the A/H1N1 pandemic, but it is uncertain whether these findings are applicable to the COVID-19 pandemic.
School closures, antiviral treatments and social distancing may not have been cost-effective in the H1N1 pandemic, but it is uncertain whether these findings are applicable to the COVID-19 pandemic.
We’ve already reached tens of thousands of people with plain language summaries of systematic reviews. If you’d like to help us to continue our work, please consider a donation.
Donate with PayPal
You can also donate through the Charities Aid Foundation (CAF) here. If you are based in the USA and want to make a tax-deductable donation, please donate to Evidence Aid via the British Schools and Universities Foundation.